FindTrial
Sign In

DS-5565

DRUG9 trials

Sponsors

Daiichi Sankyo Co., Ltd., Daiichi Sankyo

Conditions

Diabetic Peripheral Neuropathic PainDiabetic Peripheral NeuropathyFibromyalgiaPainPain Associated With FibromyalgiaPost-Herpetic NeuralgiaPost-herpetic Neuralgia

Phase 2

Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy
CompletedNCT01504412
Daiichi Sankyo Co., Ltd.Diabetic Peripheral Neuropathy, Pain
Start: 2012-01-31End: 2013-06-30Updated: 2020-03-18

Phase 3

Treatment of Pain Associated With Fibromyalgia
CompletedNCT02146430
Daiichi SankyoPain Associated With Fibromyalgia
Start: 2014-10-27End: 2016-07-14Updated: 2020-11-09
Treatment of Pain Associated With Fibromyalgia
CompletedNCT02187159
Daiichi SankyoPain Associated With Fibromyalgia
Start: 2014-11-30End: 2016-07-07Updated: 2020-11-09
Treatment of Pain Associated With Fibromyalgia
CompletedNCT02187471
Daiichi SankyoPain Associated With Fibromyalgia
Start: 2015-01-16End: 2017-01-12Updated: 2020-11-09
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
CompletedNCT02234583
Daiichi SankyoPain Associated With Fibromyalgia
Start: 2015-02-04End: 2017-04-19Updated: 2020-07-23
DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain
CompletedNCT02318706
Daiichi Sankyo Co., Ltd.Diabetic Peripheral Neuropathic Pain
Start: 2015-01-31End: 2017-06-29Updated: 2020-11-02
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
CompletedNCT02496884
Daiichi SankyoFibromyalgia
Start: 2015-06-26End: 2017-07-06Updated: 2020-11-24
DS-5565 Phase III Study for Renal Impairment in Japanese Subjects
CompletedNCT02607280
Daiichi Sankyo Co., Ltd.Diabetic Peripheral Neuropathic Pain, Post-herpetic Neuralgia
Start: 2015-12-31End: 2017-03-31Updated: 2021-05-13

Unknown Phase

DS-5565 Phase III Study for Post-herpetic Neuralgia
CompletedNCT02318719
Daiichi Sankyo Co., Ltd.Post-Herpetic Neuralgia
Start: 2015-01-31End: 2017-05-25Updated: 2020-11-02

Related Papers

Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies.
2021-05-2920 citations
Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan.
2021-02-113 citations
Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia
Medicine2020-09-0139 citations
Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.
2020-07-1713 citations
Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study.
2020-02-1219 citations
Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study
Current Medical Research and Opinion2019-07-0929 citations
Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients.
2019-02-2891 citations
Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients
Pain2019-01-24106 citations